12:37 AM ET
Earnings Call
▶ Call
Mirum Pharmaceuticals Earnings Call: Key Takeaways
Mirum Pharmaceuticals delivered a strong Q3 2026, raising full-year revenue guidance to $715M-$720M while preparing for five potential regulatory submissions in early 2027.
- Call
- Nov 3, 2026, 4:30 PM ET